Opcon-A
Opcon-A is an FDA drug label for the active ingredient NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE manufactured by Bausch & Lomb Incorporated administered by OPHTHALMIC. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231214.
- Generic name
- NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
- Manufacturer
- Bausch & Lomb Incorporated
- Product type
- HUMAN OTC DRUG
- Route
- OPHTHALMIC
- Dosage form
- N/A
- NDC
- 24208-430
- Application
- NDA020065
- Label effective
- 20231214
Active ingredients
Indications & Usage
Uses • temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander
Dosage & Administration
Directions • Adults and children 6 years of age and older: Instill 1 or 2 drops in the affected eye(s) up to 4 times daily. • Children under 6 years: ask a doctor
Contraindications
Not available.
Warnings
Warnings For external use only Do not use • if you are sensitive to any ingredient in this product • if solution changes color or becomes cloudy Ask a doctor before use if you have • heart disease • high blood pressure • trouble urinating due to an enlarged prostate gland • narrow angle glaucoma When using this product • overuse may cause more eye redness • pupils may become enlarged temporarily • do not touch tip of container to any surface to avoid contamination • you may feel a brief tingling after putting drops in eye • replace cap after use • remove contact lenses before using Stop use and ask a doctor if you experience • eye pain • changes in vision • redness or irritation of the eye that worsens or lasts more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Accidental oral ingestion in infants and children may lead to coma and marked reduction in body temperature.
Adverse Reactions
Not available.